Tranzbyte Corp. (OTCMKTS:ERBB) Climbs On Sector Hype
The last two sessions of 2013 pushed Tranzbyte Corp. (OTCMKTS:ERBB) up the charts after the ticker spent months wobbling between $0.002 and $0.001. Despite the sizable percentile movement, the ticker remained in double-zero land, stopping at $0.0029 per share.
Considering that ERBB has made no announcements since early December and those didn’t help the price move up much, the recent movement is difficult to explain. The company has not furnished any new filings either, so the green sessions may be related to a general surge across the marijuana sector.
Other pot stocks including Medical Marijuana, Inc. (OTCMKTS:MJNA) and Hemp, Inc. (OTCMKTS:HEMP) caught a nice boost as well, closing the last two sessions in double-digit green. The catalyst for this may have been the expected launch of marijuana sales for recreational use in the state of Colorado. With the first purchase executed on New Year’s Day, the sector swelled up with excitement around the first recreational legal sale of the plant.
ERBB looks like it’s just along for the ride as the company is not doing a lot on its own to improve investor confidence. The latest quarterly report from ERBB covering the three months ended September 2013 lists the following figures:
- $2.6 thousand in cash
- $4.6 million in current liabilities
- $61 thousand in quarterly revenues
- $289 thousand in net loss
The company’s subsidiaries have grown in number as ERBB is trying to diversify its business. The company acquired OneBode Holdings and Yo Corp., businesses focusing respectively on health supplements and debit card services. Even though the acquisitions took place in April and the subsidiaries’ performance should have affected ERBB‘s most recent quarterly, the numbers reported were far from stellar, considering the above numbers reflect the consolidated assets and financial situation and performance of ERBB and all its subsidiaries.
Additionally, ERBB will need to pay for the acquisitions using common stock but in a classic fit of pinksheet reporting, it listed two different figures for the OneBode acquisition – $0.5 and $2 million. Regardless, considering the share price of ERBB and the need to pay a hefty sum for the OneBode acquisition, ERBB is headed for some further considerable dilution, even though it already has 3.4 billion shares issued and outstanding.
